Extra Damages Bid In $22M Stent Suit Denied By Fed. Circ.
Spectralytics had argued to the appeals court that the $500,000 enhanced damages award by a trial judge was insufficient punishment for the willful infringement of a stent-cutting machine patent.
“That amount of money does not punish Cordis and will not stop them from doing anything at...
To view the full article, register now.